[1,2-a]

[1,2-b]

[1,2-c]

[1,2-d]

[1,2-f]

[1,2-x]

[1,5-a]

[1,5-b]

[1,5-c]

[1,5-d]

[1,6-ad][1,7-a]

[2,1-a]

[2,1-b]

[2,1-c]

[2,1-d]

[2,1-e]

[2,1-f]

[2,1-]

[2,3-a]

[2,3-b]

[2,3-c]

[2,3-d]

[2,3-e]

[2,3-f]

[2,3-g]

[2,3-h]

[2,3-ij][2,4-b]

[3,2-a]

[3,2-b]

[3,2-c]

[3,2-d]

[3,2-e]

[3,2-g]

[3,2-f]

[3,2-h]

[3,4-a]

[3,4-b]

[3,4-c]

[3,4-d]

[3,4-e]

[3,4-f]

[3,4-g]

[3,4-]

[4,3-a]

[4,3-b]

[4,3-c]

[4,3-d]

[4,3-e]

[4,3-g]

[4,3-]

[4,5-a]

[4,5-b]

[4,5-c]

[4,5-d]

[4,5-e]

[4,5-f]

[4,5-g]

[4,5-h]

[4,5-]

[5,1-a]

[5,1-b]

[5,1-c]

[5,1-f]

[5,1-]

[5,4-b]

[5,4-c]

[5,4-d]

[5,4-e]

[5,4-f]

[5,4-]

[5,6-b]

[5,6-c]

[5,6-]

[6,1-b]

[6,1-]

[6,5-b]

[6,5-]

Order 66958-15-4 2,4-Cyclohexadien-1-one,6-(6,6-dimethoxy-5-methyl-2,4-hexadienyl)-2,6-dimethyl-

Order 66959-28-2 6-nitro-2-oxo-1,2-dihydrobenzo[cd]indole-5-carboxylic acid

Order 66960-16-5 Glycine, N-[N-[N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosyl]-D-alanyl]-,compd. with N-cyclohexylcyclohexanamine (1:1)

Order 66962-53-6 1,3-Dioxolo[4,5-g]isoquinoline,benzoic acid deriv.

Order 66963-18-6 Fortimicin AS

Order 66964-25-8 MesuaferroneA

Order 66964-32-7 Acetamide, 2,2,2-trifluoro-N-[1-(1-naphthalenyl)ethyl]-, (R)-

Order 66965-37-5 5-epi-5,6-Dihydropolyangioic acid

Order 66965-49-9 (18α,19α)-Ursane-3,16-dione

Order 66965-50-2 (18α)-Urs-20-ene-3β,16β-diol diacetate

Order 66965-52-4 (18α)-Urs-20-en-16β-ol acetate

Order 66967-25-7 2H-Pyran, 2-(3,4-dimethoxyphenoxy)tetrahydro-

Order 66968-06-7 10-methylaporphine

Order 66968-11-4 Dichloro(2-furyl)arsine

Order 66968-17-0 Hexahydro-5,5,7-trimethyl-2H-azepin-2-one

Order 66968-34-1 5-Ethyl-5-(1-ethyl-1-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione

Order 66968-36-3 5-Ethyl-5-(1-ethylpropyl)-2-sodiooxy-4,6(1H,5H)-pyrimidinedione

Order 66968-38-5 5-Ethyl-5-[1-(ethylthio)-2-ethylbutyl]-2-sodiooxy-4,6(1H,5H)-pyrimidinedione

Order 66968-47-6 5-Ethyl-5-isobutenyl-2,4,6(1H,3H,5H)-pyrimidinetrione

Order 66968-48-7 5-Ethyl-5-(isobutoxymethyl)-2,4,6(1H,3H,5H)-pyrimidinetrione